EBAMed
EBAMed is a non-invasive treatment for heart arrhythmias founded in 2018.
2
Funding Rounds
$32.0m
Money raised
Overview
EBAMed is a non-invasive treatment for heart arrhythmias founded in 2018.
- Website:
- Business model: B2B
- Headquarters: Geneva
- Social accounts: linkedin
Funding series
Funding Series Analysis
The company EBAMed has raised a total of $32m in funding over 2 rounds.
Key Insights:
- EBAMed June 2023 Series A Funding Round: $16m
- EBAMed June 2023 Series A Funding Round: $16m
EBAMed June 2023 Series A Funding Round
$16m
EBAMed June 2023 Series A Funding Round
$16m